Remove Disease Remove Doctors Remove Organic Chemistry Remove RNA
article thumbnail

Women in Stem with Dr Emily Leproust

Drug Target Review

I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organic chemistry and nucleic acids chemistry. I originally wanted to be a doctor but that’s a second-tier track in France. I’m a CEO with a background in chemistry.

DNA 113
article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

She has played a key role inbuilding the target identification platform and a proprietary database of transcriptome-wide, functional RNA structures. Interactive Q&A session: Pose your questions directly to the experts and get tailored insights to your interests and concerns.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Jens Fischer, PhD, Program Manager, Large Molecule Research Therapeutic Modalities, Roche Pharma Research and Early Development (pRED), on: ‘ Bispecific and next-generation antibodies for non-oncology indications such as ophthalmologic and neurologic diseases’.